Anixa Biosciences AGM: Shareholders Back Directors as CEO Highlights CAR-T, Vaccine Progress [Yahoo! Finance]
Anixa Biosciences, Inc. (ANIX)
Last anixa biosciences, inc. earnings: 3/9 05:10 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Arnold Baskies, Emily Gottschalk and Lewis Titterton, approved the advisory "say-on-pay" vote, and ratified Haskell & White LLP as auditors at the 2026 AGM. CEO Amit Kumar emphasized a partnership-driven, low-burn strategy with a small four-person headcount and a "clean" capital structure; the company reported roughly $14 million in cash as of Jan. 21, 2026, which management said represents more than two years of runway with no debt. Anixa's CAR-T candidate liraltagene autoleucel (lira-cel) has shown favorable safety and early overall survival signals in dose-escalation cohorts and is advancing to higher doses with lymphodepletion, while the breast cancer vaccine completed Phase I with ~75% showing strong immune responses and Phase II planning underway. Interested in Anixa Biosciences Inc? Here are five stocks we like better. 3 Under-the-Radar Biotechs Under $5 That Could Soar 200% Anixa Biosciences (NASDAQ:ANIX) held its 2026 Annual Meeting of Stockholders via live webcast,
Show less
Read more
Impact Snapshot
Event Time:
ANIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIX alerts
High impacting Anixa Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
ANIX
News
- Anixa Biosciences (ANIX) was downgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=ANIX&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "holdMarketBeat
- Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast [Yahoo! Finance]Yahoo! Finance
- Anixa Biosciences Featured on Water Tower Research Healthcare Happenings PodcastPR Newswire
- Anixa Biosciences Receives Notice of Allowance from Korean Ministry of Intellectual Property (MOIP) for Patent Covering Breast Cancer Vaccine Technology [Yahoo! Finance]Yahoo! Finance
- Anixa Biosciences Receives Notice of Allowance from Korean Ministry of Intellectual Property (MOIP) for Patent Covering Breast Cancer Vaccine TechnologyPR Newswire
ANIX
Earnings
- 3/9/26 - Beat
ANIX
Sec Filings
- 3/11/26 - Form 8-K
- 3/9/26 - Form 10-Q
- 2/9/26 - Form 8-K
- ANIX's page on the SEC website